DiMeglioLA, AceriniCL, CodnerE, et al.: ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes, 2018; 19(Suppl. 27):105–114.
2.
6. Glycemic targets: standards of medical care in diabetes-2021. Diabetes Care, 2021; 44(Suppl. 1):S73–S84.
3.
BattelinoT, DanneT, BergenstalRM, et al.: Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care, 2019; 42:1593–1603.
4.
AbrahamMB, de BockM, SmithGJ, et al.: Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: a randomized clinical trial. JAMA Pediatr, 2021; 175:1227–1235.
5.
McAuleySA, LeeMH, PaldusB, et al.: Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial. Diabetes Care, 2020:dc201447.
6.
SofizadehS, PehrssonA, ÓlafsdóttirAF, LindM: Evaluation of reference metrics for continuous glucose monitoring in persons without diabetes and prediabetes. J Diabetes Sci Technol, 2022; 16:373–382.
7.
BrownSA, BasuA, KovatchevBP: Beyond HbA1c: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making. Diabet Med, 2019; 36:679–687.
